Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

NCT00342940 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of Vaccine Supplies

Conditions

Influenza

Interventions

BIOLOGICAL: influenza surface antigen inactivated vaccine

Sponsor

Novartis

Collaborators

[object Object]